News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
PILL.C
About Canntab: Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations….
Canntab (PILL.C) has been granted its 3rd patent by the Australian Patent Office. The patent was granted in relation to the Company’s proprietary cannabidiol formulations with a priority date…
There are 36 states in the US that have made medical marijuana legal with four more states expected to vote on legalization in the next 12 months. Cannabis as…
Cannabis hard tablet IP holder Canntab Therapeutics (PILL.C) continues to send product to market, announcing Wednesday they’ve fulfilled 80% of their contract with Medipharm Labs (LABS.T), bringing in another…
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature…
Jody Vance, child of the 80s and broadcasting legend, talks to Richard Goldstein, CFO and co-founder of Canntab Therapeutics on the future of medicinal cannabis with the accuracy and…
If we’re honest about it – if we’re REALLY honest about it – Canada has fumbled its advantage in the cannabis sector. First to market, first to raise hundreds…
PILL is developing solid oral dose formulations of cannabis with a product line of cannabinoid (THC & CBD) and terpenoid blends in multiple doses and timed-release combinations…